Picture of SNDL logo

SNDL — SNDL News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapValue Trap

Sndl Inc Reports Results For The Quarter Ended December 31: Earnings Summary

SNDL Inc SNDL.OQ reported quarterly adjusted earnings of 5 cents​​ per share for the quarter ended December 31.  The lone analyst forecast for the quarter was for a loss of 2 cents per share.

Revenue rose 3.7% to C$257.68 million from a year ago; analysts expected C$248.10 million.

SNDL Inc's reported EPS for the quarter was a loss of 25 cents​.

The company reported a quarterly loss of C$67.14 million.

SNDL Inc shares had fallen by 13.4% this quarter.

FORECAST CHANGES

The mean earnings estimate of analysts was unchanged in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The average consensus recommendation for the pharmaceuticals peer group is also "buy"

Wall Street's median 12-month price target for SNDL Inc is $4.75

This summary was machine generated from LSEG data March 18 at 01:31 p.m. UTC. ​All figures in Canadian dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDINGESTIMATEACTUALBEAT, MET, MISSED
Dec. 31 2024-0.020.05Beat
Sep. 30 2024-0.05-0.07Missed

Recent news on SNDL

See all news